PREVALÊNCIA DE HIPOVITAMINOSE D E ASSOCIAÇÃO COM COMPONENTES DA SÍNDROME METABÓLICA EM HOMENS AVALIADOS EM PROGRAMA DE DETECÇÃO DO CÂNCER DE PRÓSTATA
DOI:
https://doi.org/10.13102/rscdauefs.v5i1.1002Palavras-chave:
Síndrome Metabólica, Hipovitaminose D, Prevalência, Hiperglicemia, 25-hidroxi-vitamina DResumo
O objetivo deste artigo é avaliar a prevalência de hipovitaminose D e sua associação com componentes da síndrome metabólica (SM) em participantes de programa de rastreamento do câncer de próstata (CAP). Foram revisados dados de prontuários de 545 homens submetidos ao rastreamento de CAP, com idade média 57,95 ± 10,30, na região metropolitana de Feira de Santana-Bahia. Definiu-se como hipovitaminose D a concentração sérica de 25-hidroxivitamina D (25(OH)D) < 30 ng/ml. A SM e seus componentes foram analisados de acordo com os critérios do NCEP/ATPIII revisados pela AHA/NHLBI. A prevalência de hipovitaminose D foi de 33,03% [29,21-37,08%, IC95%]. A prevalência de SM foi maior nos sujeitos com hipovitaminose comparados aos indivíduos sem hipovitaminose, respectivamente 41,11% e 28,00%, (RP= 1,46 [1,16-1,86], p= 0,002). Quando analisados separadamente os componentes da SM, demonstrou-se que hiperglicemia e circunferência abdominal correlacionaram-se com hipovitaminose D, enquanto os demais componentes da síndrome metabólica não diferiram significativamente nos pacientes com e sem hipovitaminose D. Hipovitaminose D tem alta prevalência em homens com idade maior que 50 anos, e correlaciona-se com a síndrome metabólica. A deficiência é mais prevalente nos obesos e diabéticos.
Downloads
Métricas
Referências
Miller WL, Portalle AA. Genetic disorders of Vitamin D biosynthesis. Endocrinol. Metab. Clin. North Am. 1999, 28(4):825-40.
Arabi A, El Rassi R, El-Hajj Fuleihan, G. Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nat Rev Endocrinol. Oct; 2010;6(10):550-61.
Adams JS, Huewison M. Uptodate in vitamin D. J. Clin. Endocrinol. Metab. 2010; 95: 471-8.
Holick MF. Evolutions, biologic function, and recommended dietary allowances for vitamin D. In: Vitamin D: Physiology, Molecular Biology, and Clinical Applications. Totowa, New Jersey: Humana Press, 1999:1-16.
Kennel KA, Drake MT, Hurley DL. Vitamin D Deficiency in Adults: When to Test and How to Treat. Mayo Clinic Proceedings. 2010; 85(8):752-758.
Pludowski P, Holick MF, Pilz S, Wagner, CL. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun. Rev. 2013; 12(10):976-89.
Caretta N, Vigili de Kreutzenberg S, Valente U, Guarneri G, Pizzol D, Ferlin A, et al. Hypovitaminosis D is associated with lower urinary tract symptoms and benign prostate hyperplasia in type 2 diabetes. Artigo Original. American Society of Andrology and European Academy of Andrology. Andrology 2015: 1–6.
Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117(4): 503-5.
Strange RC, Shipman KE, Ramachandran S. Metabolic syndrome: review of the role of vitamin D in mediating susceptibility and outcome. World J Diabetes 2015; 6(7): 896-911.
Judd SE, Tangpricha V. Vitamin D Deficiency and Risk for Cardiovascular Disease. The American journal of the medical sciences. 2009;338(1):40-44.
Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S,Schiffrin EL, Eisenberg MJ. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;28;56(14):1113-32.
Ford ES, Ajani UA, Mcguire LC, LIU S. Concentrations of serum vitamin and metabolic syndrome among U.S adults. Diabetes Care 2005; 28:1228-30.
Martini LA, Wood RJ. Vitamin D and blood pressure connection: update on epidemiologic, clinical, and mechanistic evidence. Nutrition Reviews 2008; 66(5):291-7
Barchetta I, De Bernardinis M, Capoccia D, Baroni MG, Fontana M, et al. Hypovitaminosis D is Independently Associated with Metabolic Syndromein Obese Patients. Plos One 2013:8(7): e68689.
Maeda SS, Borba VZC, Camargo MBR, Silva DMW, Borges JL , Bandeira F , et al. Recomendações da Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) para o diagnóstico e tratamento da hipovitaminose D. Arq. Bras. Endocrinol. Metab. 2014; 58(5): 425 8.
Holick MF, BInkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011; 96(7): 1911-30.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112(17): 2735-52.
Neves JP, Silva AS, Morais LC, Diniz AS, Costa MJ, Asciutti, LS et al. 25-hydroxyvitamin D concentrations and blood pressure levels in hypertensive elderly patients. Arq. Bras. Endocrinol. Metabol. 2012; 56: 415-22.
Unger MD, Cuppari L, Titan SM, Magalhães MC, Sassari AL, Reis LM. Vitamin D status in a sunny country: where has the sun gone? Clin. Nutr. 2010; 29(6): 784-8.
Premaor MO, Alves GV, Crossetti LB, Furlanetto TW. Hyperparathyroidism secondary to hypovitaminosis D in hypoalbuminemic is less intense than in normoalbuminemic patients: a prevalence study in medical inpatients in southern Brazil. Endocrine 2004; 24:47-53.
Mckenna MJ. Differences in vitamin D status between countries in young adults and the elderly. Am. J. Med. 1992; 93:69-77.
González-Padilla E, Soria López A, González-Rodríguez E, García Santana S, Mirallave-Pescador A, Groba Marco ME, et al. High prevalence of hypovitaminosis D in medical students in Gran Canaria, Canary Islands (Spain). Endocrinol. Nutr. 2011;58:267-73.
Cabral MA, Borges CN, Maia JMC, Aires CAM, Bandeira F. Prevalence of vitamin D deficiency during the summer and its relationship with sun exposure and skin phototype in elderly men living in the tropics. Clin. Interv. Aging. 2013;8:1347-51.
Pinheiro MM, Schuch NJ, Genaro PS, Ciconelli RM, Ferraz MB, Martini LA. Nutrient intakes related to osteoporotic fractures in men and women – The Brazilian Osteoporosis Study (BRAZOS). Nutrition. Journal 2009; 8-6.
Correia, A, Azevedo, MS, Gondim, F, Bandeira, F. Ethnic aspects of vitamin D deficiency. Arq. Bras. Endocrinol. Metab. São Paulo, 2014; 58(5):540-4.
Lu, L, Yu, Z, Pan, A, Hu, FB, Franco, OH, LI, H. Plasma.
-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care. 2009; 32(7):1278-83.
Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ et al. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J. Clin. Endocrinol. Metab. 2012; 97(6):1953-61.
Hyppönen E, Boucher, BJ, Berry, DJ, Power, C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008; 57: 298-305.
Forman, JP, Giovannucci, E, Holmes, MD, Bischoff-Ferrari, HA, Tworoger, SS, Willett, WC, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49(5): 1063-1069.
Lind L, Hänni A, Lithell H, Hvarfner A, Sürensen OH, Ljunghall S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. American Journal of Hypertension 1995; 8(9): 894-901.
Nesby-O’Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC, Allen C, Doughertly C, Gunter EW, Bowman BA. Am J Clin Nutr. 2002; 76(1):187-92.
Compston JE, Vedi, S, Ledger JE, Webb A, Gazet JC, Pilkington TRE. Vitamin D status and bone histomorphometry in gross obesity. Am. J. Clin. Nutr. 1981; 34: 2359–63.
Florez H, Martinez R, Chacra W, Strickman-Stein N, Levis S. Outdoor exercise reduces the risk of hypovitaminosis D in the obese. The Journal of steroid biochemistry and molecular biology 2007; 103: 679-81.
Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am. J. Clin. Nutr. 2000; 72(3): 690–3.
Maeda SS, Kunii IS, Hayashi LF, Lazaretti-Castro M. Increases in summer serum 25-hydroxyvitamin D (25OHD) concentrations in elderly subjects in Sao Paulo, Brazil vary with age, gender and ethnicity. BMC Endocr. Disord. 2010; 10-12.
Kremer R, Campbell PP, Reinhardt T, Gilsanz V. Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J. Clin. Endocrinol. Metab. 2009; 94:67–73.
Vasques ACJ, Priore SE, Rosado LEFPL, Franceschini SCC. Utilização de medidas antropométricas para a avaliação do acúmulo de gordura visceral. Rev. Nutr. 2010; 23(1): 107-18.
